Search Page
Save citations to file
Email citations
Send citations to clipboard
Add to Collections
Add to My Bibliography
Create a file for external citation management software
Your saved search
Your RSS Feed
Filters
Results by year
Table representation of search results timeline featuring number of search results per year.
Year | Number of Results |
---|---|
2018 | 1 |
2019 | 1 |
2021 | 1 |
2022 | 1 |
2024 | 0 |
Search Results
3 results
Results by year
Filters applied: . Clear all
It looks like you are searching for an author.
Results are currently sorted by Best Match. To see the newest results first,
change the sort order to Most Recent.
Page 1
Did you mean
jiading cui
(41 results)?
Inhibitory effects of icotinib combined with antiangiogenic drugs in human non-small cell lung cancer xenograft models are better than single target drugs.
Thorac Cancer. 2022 Jan;13(2):257-264. doi: 10.1111/1759-7714.14261. Epub 2021 Dec 2.
Thorac Cancer. 2022.
PMID: 34855286
Free PMC article.
Efficacy of combined icotinib and pemetrexed in EGFR mutant lung adenocarcinoma cell line xenografts.
Cui J, Zhang Y, Su D, Li T, Li Y.
Cui J, et al.
Thorac Cancer. 2018 Sep;9(9):1156-1165. doi: 10.1111/1759-7714.12818. Epub 2018 Jul 26.
Thorac Cancer. 2018.
PMID: 30047610
Free PMC article.
Item in Clipboard
Combination of icotinib and chemotherapy as first-line treatment for advanced lung adenocarcinoma in patients with sensitive EGFR mutations: A randomized controlled study.
Xu L, Qi Q, Zhang Y, Cui J, Liu R, Li Y.
Xu L, et al. Among authors: cui j.
Lung Cancer. 2019 Jul;133:23-31. doi: 10.1016/j.lungcan.2019.05.008. Epub 2019 May 7.
Lung Cancer. 2019.
PMID: 31200823
Free article.
Clinical Trial.
Item in Clipboard
Cite
Cite